Immune response to SARS-CoV-2 in severe disease and long COVID-19, 2022, Sumi and Harada

Discussion in 'Long Covid research' started by Andy, Jul 12, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    22,399
    Location:
    Hampshire, UK
    Abstract

    COVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause life-threatening disease and/or a wide range of persistent symptoms. The general determinant of disease severity is age mainly because the immune response declines in aging patients. Here, we developed a mathematical model of the immune response to SARSCoV-2 and revealed that typical age-related risk factors such as only a several 10 % decrease in innate immune cell activity and inhibition of type-I interferon signaling by autoantibodies drastically increased the viral load. It was reported that the numbers of certain dendritic cell subsets remained less than half those in healthy donors even seven months after infection. Hence, the inflammatory response was ongoing. Our model predicted the persistent DC reduction and showed that certain patients with severe and even mild symptoms could not effectively eliminate the virus and could potentially develop long COVID.

    Open access, direct link to PDF, https://www.cell.com/iscience/pdf/S2589-0042(22)00995-6.pdf
     
    Peter Trewhitt and Trish like this.

Share This Page